Impact of gender: rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective study

18 June 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Antiarrhythmic drugs Antiarrhythmic drugs (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

6 More presentations in this session

Presentation thumbnail
Doctor I. Vogiatzis (Veria, GR)
Presentation thumbnail
Professor M. Farkowski (Warsaw, PL)
Presentation thumbnail
Professor J. De Pooter (Gent, BE)
Presentation thumbnail
Professor J. Davy (Montpellier, FR)
Presentation thumbnail
Doctor J. Osca Asensi (Valencia, ES)

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 08:30 CET